Gilead Sciences (GILD) is nearing a deal to buy biotech Immunomedics Inc for more than $20 billion, says the Wall Street Journal, which …
Which stocks have been the stars of 2020? Biotechs.
Shares in biopharma Immunomedics (IMMU) soared 29% in Wednesday’s after-market trading following an early FDA approval for Trodelvy (sacituzumab govitecan) in triple-negative breast …
Are the dark clouds that have been looming over Wall Street finally dissipating? The recent rally in stocks has generated hope among some …
Immunomedics Inc’s shares (IMMU) more than doubled after the biotech company said a study of its breast cancer drug was halted early on “compelling evidence …
Biotech stocks require only a few select indicators to send a share price soaring, or conversely, to cause it to tumble mercilessly down …
When it comes to stocks that can shoot up overnight, biotechs are the name of the game. This group’s extreme volatility lies in …
Immu-132 continues to have strong efficacy in centrally-reviewed data at SABCS, says Cowen’s Phil Nadeau.
Cowen places more importance on ORR strength than reduction in OS for IMMU’s prospects for a green light.
Greenblatt’s Gotham Management Turns Bullish on These 3 Biotech Stocks
